{"disease":{"id":"nephrotic-syndrome-minimal-change","name":"nephrotic syndrome minimal change"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03786263","title":"CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04571658","title":"NEPTUNE Match Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":375,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT05505500","title":"Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT07010250","title":"Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":146,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06315504","title":"Circulating Factors in Nephrotic Syndrome","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Iain Bressendorff","has_results":false},{"nct_id":"NCT06635720","title":"REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT03298698","title":"Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT02592798","title":"Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT05588063","title":"taVNS for FRNS in Children","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT05583942","title":"A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Northwell Health","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}